Novo

FDA 510(k) K212361 · PathAI, Inc.

Substantially Equivalent

510(k) numberK212361

Submission

Device name
Novo
Applicant
PathAI, Inc.
Boston, MA, US
Received
July 30, 2021
Decision date
August 11, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QKQ – Digital Pathology Image Viewing And Management Software
Device class
Class II (moderate risk)
Regulation
21 CFR 864.3700
Specialty
Pathology

Digital pathology image viewing and management software device is a software intended for viewing and management of digital images of scanned surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue. It is an aid to the pathologist to review and interpret these digital images for the purposes of primary diagnosis.

Other 510(k)s with product code QKQ

510(k)DeviceApplicantDecision
K261380Concentriq AP-DxQKQ · Traditional Proscia, Inc.08/05/2026SE
K243449Infinitt DPSQKQ · Traditional Infinitt Healthcare Co., Ltd.12/09/2025SE
K252762HALO AP DxQKQ · Traditional Indica Labs, LLC11/25/2025SE
K243391AISight DxQKQ · Traditional PathAI, Inc.06/26/2025SE
K250968PathPresenter Clinical ViewerQKQ · Traditional Pathpresenter Corporation06/20/2025SE
K250414CaloPixQKQ · Traditional Tribun Health05/14/2025SE
K242244Viewer+QKQ · Traditional Lumea, Inc.03/14/2025SE
K241273FullFocusQKQ · Traditional Paige.Ai, Inc.01/09/2025SE
K240303MetaLite DX Digital Pathology SoftwareQKQ · Traditional Jellox Biotech, Inc.10/28/2024SE
K233126aetherSlideQKQ · Traditional Aetherai Co., Ltd.05/30/2024SE

More from Aetherai Co., Ltd.

510(k)DeviceDecision
K243391AISight DxQKQ · Traditional 06/26/2025SE

Questions and answers

When was Novo cleared by the FDA?

Novo (K212361) received a 510(k) decision of Substantially Equivalent on August 11, 2022, 377 days after the submission was received.

What is the product code of K212361?

The FDA product code is QKQ – Digital Pathology Image Viewing And Management Software, a Class II (moderate risk) device regulated under 21 CFR 864.3700.